Presentation is loading. Please wait.

Presentation is loading. Please wait.

Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm,

Published byΧαρικλώ Γιαννόπουλος Modified over 5 years ago

Similar presentations

Presentation on theme: "Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm,"— Presentation transcript:

1 Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm, MD, Balthasar Eberle, MD, Frank Krummenauer, PhD, Stefan Guth, MD, Hellmut Oelert, MD, Eckhard Mayer, MD  The Annals of Thoracic Surgery  Volume 76, Issue 3, Pages (September 2003) DOI: /S (03)

2 Fig 1 Preoperative and postoperative changes of (A) cardiac index (CI), (B) mean pulmonary artery pressure (mPAP), and (C) mean systemic pressure (mAP) during and after normal saline (NaCl) (not significant) followed by iloprost (Ilo) inhalation. (ICU = intensive care unit.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

3 Fig 2 (A) Preoperative and (B, C) postoperative time courses of systemic (▴) and pulmonary vascular resistance (■) during iloprost inhalation. (B) ICU admission. (C) 12 h postoperatively. (ICU = intensive care unit; PVR = pulmonary vascular resistance; SVR = systemic vascular resistance.) ▴ = SVR/dynes · s · cm−5; ■ = PVR/dynes · s · cm−5. The Annals of Thoracic Surgery  , DOI: ( /S (03) )

4 Fig 3 Calculated PVR/SVR ratio during iloprost inhalation at (A) T1, (B) T2, and (C) T3. (A) Increase of ratio demonstrating overwhelming systemic side effects with premature abort of measurements (50 minutes), *p less than 0.05 versus ILO-start. (B, C) Significant decrease of ratio indicating predominant pulmonary vasodilatation, *p less than 0.05, §p less than 0.01 versus ILO-start. (ILO = iloprost; PVR = pulmonary vascular resistance; SVR = systemic vascular resistance.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

5 Fig 3 Calculated PVR/SVR ratio during iloprost inhalation at (A) T1, (B) T2, and (C) T3. (A) Increase of ratio demonstrating overwhelming systemic side effects with premature abort of measurements (50 minutes), *p less than 0.05 versus ILO-start. (B, C) Significant decrease of ratio indicating predominant pulmonary vasodilatation, *p less than 0.05, §p less than 0.01 versus ILO-start. (ILO = iloprost; PVR = pulmonary vascular resistance; SVR = systemic vascular resistance.) The Annals of Thoracic Surgery  , DOI: ( /S (03) )

Download ppt "Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy  Thorsten Kramm,"

Similar presentations

Intraoperative Pulmonary Artery Stenting: An Alternative Technique for the Management of Pulmonary Artery Stenosis  Fotios A. Mitropoulos, MD, PhD, Hillel.

Intraoperative Pulmonary Artery Stenting: An Alternative Technique for the Management of Pulmonary Artery Stenosis  Fotios A. Mitropoulos, MD, PhD, Hillel.
Transplantation of lungs from non–heart-beating donors after functional assessment ex vivo  Stig Steen, MD, PhD, Qiuming Liao, MD, Per N Wierup, MD, Ramunas.

Transplantation of lungs from non–heart-beating donors after functional assessment ex vivo  Stig Steen, MD, PhD, Qiuming Liao, MD, Per N Wierup, MD, Ramunas.
Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery

Oral Sildenafil Reduces Pulmonary Hypertension After Cardiac Surgery
Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest 

Effect of a Single Bolus of Erythropoietin on Renoprotection in Patients Undergoing Thoracic Aortic Surgery With Moderate Hypothermic Circulatory Arrest 
Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M
Fibrinogen Levels After Cardiac Surgical Procedures: Association With Postoperative Bleeding, Trigger Values, and Target Values  Marco Ranucci, MD, Valeria.

Fibrinogen Levels After Cardiac Surgical Procedures: Association With Postoperative Bleeding, Trigger Values, and Target Values  Marco Ranucci, MD, Valeria.
Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy  Thomas Menzel, MD, Thorsten Kramm, MD, Stephan Wagner, MD, Susanne Mohr-Kahaly,

Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy  Thomas Menzel, MD, Thorsten Kramm, MD, Stephan Wagner, MD, Susanne Mohr-Kahaly,
Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction  Theofani Antoniou, MD, PhD, Christos Prokakis, MD,

Inhaled Nitric Oxide Plus Iloprost in the Setting of Post-Left Assist Device Right Heart Dysfunction  Theofani Antoniou, MD, PhD, Christos Prokakis, MD,
Sodium nitroprusside mitigates oleic acid-induced acute lung injury

Sodium nitroprusside mitigates oleic acid-induced acute lung injury
Francis L. Shannon, MD, Frank L. Fazzalari, MD, MBA, Patricia F

Francis L. Shannon, MD, Frank L. Fazzalari, MD, MBA, Patricia F
Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.

Effect of modified ultrafiltration in high-risk patients undergoing operations for congenital heart disease1  Ko Bando, MD, Mark W Turrentine, MD, Palaniswamy.
Cardiac Operations in Solid-Organ Transplant Recipients

Cardiac Operations in Solid-Organ Transplant Recipients
What is the marginal cost for marginal risk in cardiac surgery?

What is the marginal cost for marginal risk in cardiac surgery?
Metabolic and Hemodynamic Effects of High-Dose Insulin Treatment in Aortic Valve and Coronary Surgery  Juha K. Koskenkari, MD, Päivi K. Kaukoranta, MD,

Metabolic and Hemodynamic Effects of High-Dose Insulin Treatment in Aortic Valve and Coronary Surgery  Juha K. Koskenkari, MD, Päivi K. Kaukoranta, MD,
Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication?  Nishant D. Patel, BA, Jason.
Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G

Jennifer K. Peterson, MS, Lazaros K. Kochilas, MD, MSCR, Kirsti G
Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis

Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis
Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,

Simple Index to Predict Likelihood of Skilled Nursing Facility Admission After Coronary Artery Bypass Grafting Among Older Patients  David C. Chang, PhD,
Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization  Mark Yeatman, Massimo Caputo, MD, Pradeep Narayan,

Magnesium-supplemented warm blood cardioplegia in patients undergoing coronary artery revascularization  Mark Yeatman, Massimo Caputo, MD, Pradeep Narayan,
Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation  Franz X Schmid, MD, Bernd Nowak, MD, Christoph.

Cardiac pacing in premature infants and neonates: steroid eluting leads and automatic output adaptation  Franz X Schmid, MD, Bernd Nowak, MD, Christoph.

Similar presentations

Ads by Google